Nanotechnology and Antivirus Nanomaterials for Combating COVID-19
Strategies against SARS-CoV-2 Variants in the Post-pandemic Era
- 1st Edition - December 1, 2025
- Latest edition
- Editor: Jen-Tsung Chen
- Language: English
Nanotechnology and Antivirus Nanomaterials for Combating COVID-19: Strategies against SARS-CoV-2 Variants in the Post-pandemic Era explores the state-of-the-art and advanc… Read more
Nanotechnology and Antivirus Nanomaterials for Combating COVID-19: Strategies against SARS-CoV-2 Variants in the Post-pandemic Era explores the state-of-the-art and advancements in nanotechnology to fight SARS-CoV-2 and its variants. Providing a comprehensive overview, the chapters cover the molecular mechanisms of viral infection and advanced tools for diagnosis, prevention, treatments, drug development, and vaccine creation, offering valuable insights into managing COVID-19. The book also includes discussions on potential challenges and future research directions. This book is a valuable resource for researchers, scientists, and professionals seeking a deeper understanding of nanotechnology's applications for preventing, diagnosing, and managing COVID-19.
- Highlights cutting-edge tools and recent applications of nanotechnology in the fight against SARS-CoV-2.
- Outlines the latest accomplishments in COVID-19 management through nanomaterial-based strategies.
- Presents up-to-date insights into the role of nanotechnology in the development of COVID-19 vaccines
Researchers and scientists in the fields of nanotechnology, materials science, and those engaged in nanotechnology-based applications and SARS-CoV-2 infections.
1. A comprehensive review of epidemiology, virology, and prevention for COVID-19 and its variants
2. Coronavirus Disease 2019 and the SARS-CoV-2 variants: Virological perspectives
3. Introduction to antiviral nanomaterials: Mechanisms and applications
4. An overview of antiviral nanomedicine: Types, structures and functions
5. Nanotechnology-based strategies for combating SARS-CoV-2 variants
6. Nanotechnology for diagnosis of COVID-19: Current achievements and future directions
7. Nanomaterial-based therapeutic drugs for SARS-CoV-2 variants: Recent finding, limitations, and prospects
8. The development of lipid nanoparticle technology for the management of COVID-19
9. Nanotechnology for the prevention of SARS-CoV-2 infection
10. Nanotechnology-assisted therapeutic antibodies against SARS-CoV-2 variants: Current findings and future perspectives
11. COVID-19 drug delivery: Current achievements and the impact of nanocarriers
12. Nanotechnology-based drug delivery for combating SARS-CoV-2 variants
13. An overview of COVID-19 vaccine development: Highlighting the role of nanotechnology
14. Nanotechnology-based vaccine development for COVID-19
15. An updated overview of clinical trials, official approval, and risks for the application of nanomaterials in COVID-19 management
16. Anti-SARS-CoV-2 nanoparticles: Mechanisms and applications
17. Engineered nanoparticles for the management of COVID-19 and new variants of SARS-CoV-2
18. Nature’s arsenal: Combatting SARS-CoV-2 variants with phytocompound nanoparticles
19. Emerging nanomaterials for COVID-19 therapeutics
20. Metallic nanoparticles-based strategies for COVID-19 management in the post-pandemic era
21.. Nanotechnological Approaches for COVID-19 Management: Highlighting the Impact on SARS-Co-V-2 Variants
22. Advancing Pandemic Response: The Impact of Nanodiagnostics on COVID-19 and Other Infectious Diseases
2. Coronavirus Disease 2019 and the SARS-CoV-2 variants: Virological perspectives
3. Introduction to antiviral nanomaterials: Mechanisms and applications
4. An overview of antiviral nanomedicine: Types, structures and functions
5. Nanotechnology-based strategies for combating SARS-CoV-2 variants
6. Nanotechnology for diagnosis of COVID-19: Current achievements and future directions
7. Nanomaterial-based therapeutic drugs for SARS-CoV-2 variants: Recent finding, limitations, and prospects
8. The development of lipid nanoparticle technology for the management of COVID-19
9. Nanotechnology for the prevention of SARS-CoV-2 infection
10. Nanotechnology-assisted therapeutic antibodies against SARS-CoV-2 variants: Current findings and future perspectives
11. COVID-19 drug delivery: Current achievements and the impact of nanocarriers
12. Nanotechnology-based drug delivery for combating SARS-CoV-2 variants
13. An overview of COVID-19 vaccine development: Highlighting the role of nanotechnology
14. Nanotechnology-based vaccine development for COVID-19
15. An updated overview of clinical trials, official approval, and risks for the application of nanomaterials in COVID-19 management
16. Anti-SARS-CoV-2 nanoparticles: Mechanisms and applications
17. Engineered nanoparticles for the management of COVID-19 and new variants of SARS-CoV-2
18. Nature’s arsenal: Combatting SARS-CoV-2 variants with phytocompound nanoparticles
19. Emerging nanomaterials for COVID-19 therapeutics
20. Metallic nanoparticles-based strategies for COVID-19 management in the post-pandemic era
21.. Nanotechnological Approaches for COVID-19 Management: Highlighting the Impact on SARS-Co-V-2 Variants
22. Advancing Pandemic Response: The Impact of Nanodiagnostics on COVID-19 and Other Infectious Diseases
- Edition: 1
- Latest edition
- Published: December 1, 2025
- Language: English
JC
Jen-Tsung Chen
Jen-Tsung Chen is a Professor of Cell Biology at the National University of Kaohsiung in Taiwan. He teaches cell biology, genomics, proteomics, plant physiology, and plant biotechnology. His research spans bioactive compounds, chromatography techniques, plant molecular biology and biotechnology, bioinformatics, and systems pharmacology. An active book and journal editor, he serves on editorial boards and has guest-edited special issues for several international journals. Dr. Chen has authored and edited books with international publishers on diverse topics including drug discovery, herbal medicine, medicinal biotechnology, nanotechnology, bioengineering, plant functional genomics, plant speed breeding, CRISPR-based plant genome editing, and artificial intelligence. In 2023 and 2024, he was listed by Elsevier and Stanford University among the 'World’s Top 2% Scientists' and also received the Springer Nature Editor of Distinction Award in 2025.
Affiliations and expertise
Professor, Department of Life Sciences, National University of Kaohsiung, Kaohsiung, Nanzih District, Taiwan